Impact of frailty metabolic phenotypes on the management of older people with type 2 diabetes mellitus

Aims To provide a pathophysiological basis for distinguishing metabolic variants of the frailty phenotype in older adults with type 2 diabetes. Methods We have made an in‐depth review of the possible mechanisms in diabetes, ageing and frailty that will alter allow us to describe phenotypic changes w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Geriatrics & gerontology international 2021-08, Vol.21 (8), p.614-622
Hauptverfasser: Abdelhafiz, Ahmed H, Emmerton, Demelza, Sinclair, Alan J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 622
container_issue 8
container_start_page 614
container_title Geriatrics & gerontology international
container_volume 21
creator Abdelhafiz, Ahmed H
Emmerton, Demelza
Sinclair, Alan J
description Aims To provide a pathophysiological basis for distinguishing metabolic variants of the frailty phenotype in older adults with type 2 diabetes. Methods We have made an in‐depth review of the possible mechanisms in diabetes, ageing and frailty that will alter allow us to describe phenotypic changes which might assist in predicting responses to particular glucose‐lowering therapy. Results Our review has enable us to describe with some confidence a sarcopenic obese phenotype and an anorexic malnourished phenotype. Conclusions By identifying these two phenotypes we can predict which would be most responsive to certain classes of therapy and where therapies may be ill‐advised. This represents the first novel approach in this area. Further work is being planned to develop this hypothesis. Geriatr Gerontol Int 2021; 21: 614–622.
doi_str_mv 10.1111/ggi.14214
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2543705319</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2557241144</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3544-62712b4dd362f5df58401d9a26de38e6d35fb7c8100cc73aac4cbb81275c82163</originalsourceid><addsrcrecordid>eNp10EFLwzAYBuAiCs7pwX8Q8KKHbvnSpO2OIjoHAy96Lmnydctom9qkjP57s9WTYC7J4XnDyxtF90AXEM5ytzML4Az4RTQDzrOYihW_PL95DCJPr6Mb5w6UQrYCmEXVpumk8sRWpOqlqf1IGvSytLVRpNtja_3YoSO2JX6PpJGt3GGD7Tlha4096dB2NZKj8XtywoQRbWSJPsQarGvjB3cbXVWydnj3e8-jr7fXz5f3ePux3rw8b2OViFAwZRmwkmudpKwSuhI5p6BXkqUakxxTnYiqzFQOlCqVJVIqrsoyB5YJlTNIk3n0OP3b9fZ7QOeLxjgVSsgW7eAKJniSUZHAKtCHP_Rgh74N7YISGeMQNgvqaVKqt871WBVdbxrZjwXQ4rR4ERYvzosHu5zs0dQ4_g-L9XozJX4ArE-B8A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2557241144</pqid></control><display><type>article</type><title>Impact of frailty metabolic phenotypes on the management of older people with type 2 diabetes mellitus</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Abdelhafiz, Ahmed H ; Emmerton, Demelza ; Sinclair, Alan J</creator><creatorcontrib>Abdelhafiz, Ahmed H ; Emmerton, Demelza ; Sinclair, Alan J</creatorcontrib><description>Aims To provide a pathophysiological basis for distinguishing metabolic variants of the frailty phenotype in older adults with type 2 diabetes. Methods We have made an in‐depth review of the possible mechanisms in diabetes, ageing and frailty that will alter allow us to describe phenotypic changes which might assist in predicting responses to particular glucose‐lowering therapy. Results Our review has enable us to describe with some confidence a sarcopenic obese phenotype and an anorexic malnourished phenotype. Conclusions By identifying these two phenotypes we can predict which would be most responsive to certain classes of therapy and where therapies may be ill‐advised. This represents the first novel approach in this area. Further work is being planned to develop this hypothesis. Geriatr Gerontol Int 2021; 21: 614–622.</description><identifier>ISSN: 1444-1586</identifier><identifier>EISSN: 1447-0594</identifier><identifier>DOI: 10.1111/ggi.14214</identifier><language>eng</language><publisher>Kyoto, Japan: John Wiley &amp; Sons Australia, Ltd</publisher><subject>Diabetes ; Frailty ; Genotype &amp; phenotype ; management ; Metabolism ; Older people ; phenotype</subject><ispartof>Geriatrics &amp; gerontology international, 2021-08, Vol.21 (8), p.614-622</ispartof><rights>2021 Japan Geriatrics Society.</rights><rights>2021 Japan Geriatrics Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3544-62712b4dd362f5df58401d9a26de38e6d35fb7c8100cc73aac4cbb81275c82163</citedby><cites>FETCH-LOGICAL-c3544-62712b4dd362f5df58401d9a26de38e6d35fb7c8100cc73aac4cbb81275c82163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fggi.14214$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fggi.14214$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Abdelhafiz, Ahmed H</creatorcontrib><creatorcontrib>Emmerton, Demelza</creatorcontrib><creatorcontrib>Sinclair, Alan J</creatorcontrib><title>Impact of frailty metabolic phenotypes on the management of older people with type 2 diabetes mellitus</title><title>Geriatrics &amp; gerontology international</title><description>Aims To provide a pathophysiological basis for distinguishing metabolic variants of the frailty phenotype in older adults with type 2 diabetes. Methods We have made an in‐depth review of the possible mechanisms in diabetes, ageing and frailty that will alter allow us to describe phenotypic changes which might assist in predicting responses to particular glucose‐lowering therapy. Results Our review has enable us to describe with some confidence a sarcopenic obese phenotype and an anorexic malnourished phenotype. Conclusions By identifying these two phenotypes we can predict which would be most responsive to certain classes of therapy and where therapies may be ill‐advised. This represents the first novel approach in this area. Further work is being planned to develop this hypothesis. Geriatr Gerontol Int 2021; 21: 614–622.</description><subject>Diabetes</subject><subject>Frailty</subject><subject>Genotype &amp; phenotype</subject><subject>management</subject><subject>Metabolism</subject><subject>Older people</subject><subject>phenotype</subject><issn>1444-1586</issn><issn>1447-0594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp10EFLwzAYBuAiCs7pwX8Q8KKHbvnSpO2OIjoHAy96Lmnydctom9qkjP57s9WTYC7J4XnDyxtF90AXEM5ytzML4Az4RTQDzrOYihW_PL95DCJPr6Mb5w6UQrYCmEXVpumk8sRWpOqlqf1IGvSytLVRpNtja_3YoSO2JX6PpJGt3GGD7Tlha4096dB2NZKj8XtywoQRbWSJPsQarGvjB3cbXVWydnj3e8-jr7fXz5f3ePux3rw8b2OViFAwZRmwkmudpKwSuhI5p6BXkqUakxxTnYiqzFQOlCqVJVIqrsoyB5YJlTNIk3n0OP3b9fZ7QOeLxjgVSsgW7eAKJniSUZHAKtCHP_Rgh74N7YISGeMQNgvqaVKqt871WBVdbxrZjwXQ4rR4ERYvzosHu5zs0dQ4_g-L9XozJX4ArE-B8A</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Abdelhafiz, Ahmed H</creator><creator>Emmerton, Demelza</creator><creator>Sinclair, Alan J</creator><general>John Wiley &amp; Sons Australia, Ltd</general><general>Blackwell Publishing Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>202108</creationdate><title>Impact of frailty metabolic phenotypes on the management of older people with type 2 diabetes mellitus</title><author>Abdelhafiz, Ahmed H ; Emmerton, Demelza ; Sinclair, Alan J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3544-62712b4dd362f5df58401d9a26de38e6d35fb7c8100cc73aac4cbb81275c82163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Diabetes</topic><topic>Frailty</topic><topic>Genotype &amp; phenotype</topic><topic>management</topic><topic>Metabolism</topic><topic>Older people</topic><topic>phenotype</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdelhafiz, Ahmed H</creatorcontrib><creatorcontrib>Emmerton, Demelza</creatorcontrib><creatorcontrib>Sinclair, Alan J</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Geriatrics &amp; gerontology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdelhafiz, Ahmed H</au><au>Emmerton, Demelza</au><au>Sinclair, Alan J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of frailty metabolic phenotypes on the management of older people with type 2 diabetes mellitus</atitle><jtitle>Geriatrics &amp; gerontology international</jtitle><date>2021-08</date><risdate>2021</risdate><volume>21</volume><issue>8</issue><spage>614</spage><epage>622</epage><pages>614-622</pages><issn>1444-1586</issn><eissn>1447-0594</eissn><abstract>Aims To provide a pathophysiological basis for distinguishing metabolic variants of the frailty phenotype in older adults with type 2 diabetes. Methods We have made an in‐depth review of the possible mechanisms in diabetes, ageing and frailty that will alter allow us to describe phenotypic changes which might assist in predicting responses to particular glucose‐lowering therapy. Results Our review has enable us to describe with some confidence a sarcopenic obese phenotype and an anorexic malnourished phenotype. Conclusions By identifying these two phenotypes we can predict which would be most responsive to certain classes of therapy and where therapies may be ill‐advised. This represents the first novel approach in this area. Further work is being planned to develop this hypothesis. Geriatr Gerontol Int 2021; 21: 614–622.</abstract><cop>Kyoto, Japan</cop><pub>John Wiley &amp; Sons Australia, Ltd</pub><doi>10.1111/ggi.14214</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1444-1586
ispartof Geriatrics & gerontology international, 2021-08, Vol.21 (8), p.614-622
issn 1444-1586
1447-0594
language eng
recordid cdi_proquest_miscellaneous_2543705319
source Wiley Online Library Journals Frontfile Complete
subjects Diabetes
Frailty
Genotype & phenotype
management
Metabolism
Older people
phenotype
title Impact of frailty metabolic phenotypes on the management of older people with type 2 diabetes mellitus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T12%3A44%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20frailty%20metabolic%20phenotypes%20on%20the%20management%20of%20older%20people%20with%20type%202%20diabetes%20mellitus&rft.jtitle=Geriatrics%20&%20gerontology%20international&rft.au=Abdelhafiz,%20Ahmed%20H&rft.date=2021-08&rft.volume=21&rft.issue=8&rft.spage=614&rft.epage=622&rft.pages=614-622&rft.issn=1444-1586&rft.eissn=1447-0594&rft_id=info:doi/10.1111/ggi.14214&rft_dat=%3Cproquest_cross%3E2557241144%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2557241144&rft_id=info:pmid/&rfr_iscdi=true